Symbol="ALNY"
AssetType="Common Stock"
Name="Alnylam Pharmaceuticals Inc"
Description="Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts."
CIK="1178670"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="23135685000"
EBITDA="-774137024"
PERatio="None"
PEGRatio="-0.49"
BookValue="-3.268"
DividendPerShare="0"
DividendYield="0"
EPS="-8.74"
RevenuePerShareTTM="10.01"
ProfitMargin="-0.86"
OperatingMarginTTM="-0.668"
ReturnOnAssetsTTM="-0.153"
ReturnOnEquityTTM="-15.01"
RevenueTTM="1237385000"
GrossProfitTTM="868601000"
DilutedEPSTTM="-8.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.418"
AnalystTargetPrice="246.47"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.37"
PriceToBookRatio="142.92"
EVToRevenue="28.64"
EVToEBITDA="-29.42"
Beta="0.482"
num_52WeekHigh="242.97"
num_52WeekLow="179.19"
num_50DayMovingAverage="194.55"
num_200DayMovingAverage="206.5"
SharesOutstanding="124526000"
DividendDate="None"
ExDividendDate="None"
symbol="ALNY"
open="184.11"
high="187.45"
low="184.11"
price="185.79"
volume="358810.00"
latest_trading_day="2023-08-11"
previous_close="185.03"
change="0.76"
change_percent="0.4107%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="68"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="32"
Volume_recent_avg="632684"
Change_recent_avg="-0.14"
Delta_recent_avg="5.56"
Variance_recent_avg="2.78"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="1141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0174.jpeg"
image_negative_thumbnail_id_2="156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0020.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="558"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_positive_thumbnail_id_1="671"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_positive_thumbnail_id_2="676"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
